Alto Neuroscience Inc. (NYSE: ANRO) reported financial results for the full year ending December 31, 2023, on March 21, 2024. The company has no revenue at this stage. Alto reported a net loss of $36.3 million for 2023 versus $27.7 million for 2022. The net cash used in operating activities was $33.4 million for 2023 […]
Enveric Biosciences (NASDAQ: ENVB) reported financial results for the fourth quarter of 2023 and the fiscal year ending December 31, 2023. The company has no revenue to report as of yet. Enveric did deliver a net loss of $3.44 million for the quarter, including $1.48 million in net non-cash expenses. This translated to a basic […]
Last week, Germany’s upper house, the Bundesrat (made up of federal state delegates), passed legislation to legalize cannabis starting April 1, 2024, but with limitations. The move prompted several cannabis stocks to jump on the hope for additional revenue streams. Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) watched its stock pop by 68% on Friday, […]
The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis